Foundation Medicine Secures $42,500,000 Series B Financing

  • Feed Type
  • Date
    9/21/2012
  • Company Name
    Foundation Medicine
  • Mailing Address
    One Kendall Square Boston, MA 02139
  • Company Description
    The trick to beating cancer could be a single test that shows all known genetic traits in each person’s tumor, and that also matches those results to the best treatments.
  • Website
    http://www.foundationmedicine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $42,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds from the financing will help Foundation Medicine expand commercial operations, scale laboratory capabilities and develop additional genomic profiling and information services.
  • M&A Terms
  • Venture Investor
    Deerfield Capital
  • Venture Investor
    Casdin Capital
  • Venture Investor
    Redmile Group
  • Venture Investor
    Roche Venture Fund
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Google Ventures
  • Venture Investor
    Kleiner Perkins Caufield & Byers

By posting a comment, you agree to our terms and conditions.